These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 26409664)

  • 41. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene].
    Schiphorst RH; van de Kar NC; van den Heuvel LP
    Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
    Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
    BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombotic thrombocytopenic purpura.
    Lämmle B; Kremer Hovinga JA; Alberio L
    J Thromb Haemost; 2005 Aug; 3(8):1663-75. PubMed ID: 16102032
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An update on pathogenesis and diagnosis of thrombotic thrombocytopenic purpura.
    Joly BS; Coppo P; Veyradier A
    Expert Rev Hematol; 2019 Jun; 12(6):383-395. PubMed ID: 31107120
    [No Abstract]   [Full Text] [Related]  

  • 47. Safety and effectiveness of eculizumab for pediatric patients with atypical hemolytic-uremic syndrome in Japan: interim analysis of post-marketing surveillance.
    Ito S; Hidaka Y; Inoue N; Kaname S; Kato H; Matsumoto M; Miyakawa Y; Mizuno M; Okada H; Shimono A; Matsuda T; Maruyama S; Fujimura Y; Nangaku M; Kagami S
    Clin Exp Nephrol; 2019 Jan; 23(1):112-121. PubMed ID: 30039480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure.
    Shibagaki Y; Matsumoto M; Kokame K; Ohba S; Miyata T; Fujimura Y; Fujita T
    Nephrol Dial Transplant; 2006 May; 21(5):1289-92. PubMed ID: 16449289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.
    Peyvandi F; Rossio R; Ferrari B; Lotta LA; Pontiggia S; Ghiringhelli Borsa N; Pizzuti M; Donadelli R; Piras R; Cugno M; Noris M
    J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathogenesis of thrombotic microangiopathies.
    Zheng XL; Sadler JE
    Annu Rev Pathol; 2008; 3():249-77. PubMed ID: 18215115
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular biology of thrombotic microangiopathy.
    Tsai HM
    Kidney Int; 2006 Jul; 70(1):16-23. PubMed ID: 16760911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Siblings with congenital thrombotic thrombocytopenic purpura].
    Funakoshi Y; Okada M; Matsumoto M; Kokame K; Moriuchi H
    Rinsho Ketsueki; 2017; 58(8):933-937. PubMed ID: 28883277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [ADAMTS13, von Willebrand factor specific cleaving protease].
    Veyradier A; Coppo P
    Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryptic activity of atypical hemolytic uremic syndrome and eculizumab treatment.
    Belingheri M; Possenti I; Tel F; Paglialonga F; Testa S; Salardi S; Ardissino G
    Pediatrics; 2014 Jun; 133(6):e1769-71. PubMed ID: 24843058
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnostic and Therapeutic Challenges in Atypical Hemolytic Uremic Syndrome: A Case Report].
    Reis S; Ramos D; Cordinhã C; Gomes C
    Acta Med Port; 2019 Oct; 32(10):673-675. PubMed ID: 31625881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inherited thrombotic thrombocytopenic purpura in pregnancy.
    Drews K; Seremak-Mrozikiewicz A; Sobieszczyk S; Barlik M
    Neuro Endocrinol Lett; 2013; 34(6):508-13. PubMed ID: 24378452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura.
    Lotta LA; Garagiola I; Palla R; Cairo A; Peyvandi F
    Hum Mutat; 2010 Jan; 31(1):11-9. PubMed ID: 19847791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.